Sydney scientist behind ‘moon landing’ cancer vaccine wins top science prize
Professor Georgina Long has been awarded Australia's Eureka Prize for her leadership in a landmark phase 3 trial for a personalized mRNA melanoma vaccine. The vaccine, developed by Moderna and Merck, aims to prevent cancer recurrence and has shown significant clinical promise.
Why it matters
Advancements in mRNA cancer vaccines represent a potential paradigm shift in oncology and personalized medicine.
Save You have reached your maximum number of saved items.
Remove items from your saved list to add more.
Share A A A The scientist who transformed advanced melanoma into a treatable cancer and led a recent large-scale trial into a world-first personalised mRNA cancer vaccine has won the research prize at Australia’s premier science awards.
Professor Georgina Long was cautious to discuss the melanoma vaccine trial given that full results won’t be released until October, but described it as an “absolute landmark, fork-in-the-road for cancer” ahead of being awarded the Eureka Prize for Scientific Research at the Australian Museum on Thursday night.
Professor Georgina Long has won the Eureka Prize for Scientific Research. Tim Bauer “It represents a huge body of work and team effort, and it’s an honour, really, to represent all the people that I lead,” the former Australian of the Year said of the award.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in